A Strong Case for Viral Genetic Factors in HIV Virulence
暂无分享,去创建一个
[1] Ard van Sighem,et al. Viral Load Levels Measured at Set-Point Have Risen Over the Last Decade of the HIV Epidemic in the Netherlands , 2009, PloS one.
[2] Douglas D. Richman,et al. Viral Dynamics of Acute HIV-1 Infection , 1999, The Journal of experimental medicine.
[3] Lei Wang,et al. A multicenter observational study of the potential benefits of initiating combination antiretroviral therapy during acute HIV infection. , 2006, The Journal of infectious diseases.
[4] A. Sönnerborg,et al. Kinetics of HIV-1 RNA and resistance-associated mutations after cessation of antiretroviral combination therapy , 2001, AIDS.
[5] S. Harrison,et al. Long-COVID Symptoms in Individuals Infected with Different SARS-CoV-2 Variants of Concern: A Systematic Review of the Literature , 2022, Viruses.
[6] B. Walker,et al. Evolution of HLA-B*5703 HIV-1 escape mutations in HLA-B*5703–positive individuals and their transmission recipients , 2009, The Journal of experimental medicine.
[7] N. Mehra,et al. Genetic determinants of HIV-1 infection and progression to AIDS: immune response genes. , 2009, Tissue antigens.
[8] Konrad Scheffler,et al. Evidence of HIV-1 adaptation to host HLA alleles following chimp-to-human transmission , 2009, Virology Journal.
[9] P. Massip,et al. CXCR4-using viruses in plasma and peripheral blood mononuclear cells during primary HIV-1 infection and impact on disease progression , 2010, AIDS.
[10] Philippe Froguel,et al. Genomewide association study of an AIDS-nonprogression cohort emphasizes the role played by HLA genes (ANRS Genomewide Association Study 02). , 2009, The Journal of infectious diseases.
[11] Marion Cornelissen,et al. HIV RNA levels in transmission sources only weakly predict plasma viral load in recipients. , 2010, AIDS.
[12] John W. Mellors,et al. Prognosis in HIV-1 Infection Predicted by the Quantity of Virus in Plasma , 1996, Science.
[13] W. G. Hill,et al. Heritability in the genomics era — concepts and misconceptions , 2008, Nature Reviews Genetics.
[14] J. S. Sullivan,et al. Genomic Structure of an Attenuated Quasi Species of HIV-1 from a Blood Transfusion Donor and Recipients , 1995, Science.
[15] J. Goedert,et al. Multistage genomewide association study identifies a locus at 1q41 associated with rate of HIV-1 disease progression to clinical AIDS. , 2010, The Journal of infectious diseases.
[16] J. Bull,et al. Short-sighted evolution and the virulence of pathogenic microorganisms. , 1994, Trends in microbiology.
[17] J. Margolick,et al. Lack of Evidence for Changing Virulence of HIV-1 in North America , 2008, PloS one.
[18] T. Klimkait,et al. HIV-1 coreceptor usage and CXCR4-specific viral load predict clinical disease progression during combination antiretroviral therapy , 2008, AIDS.
[19] I. Thior,et al. Human immunodeficiency virus type 1 subtypes differ in disease progression. , 1999, The Journal of infectious diseases.
[20] Sebastian Bonhoeffer,et al. Stable virulence levels in the HIV epidemic of Switzerland over two decades , 2006, AIDS.
[21] I. Bartha,et al. Has HIV evolved to induce immune pathogenesis? , 2008, Trends in immunology.
[22] C. Moore,et al. Evidence of HIV-1 Adaptation to HLA-Restricted Immune Responses at a Population Level , 2002, Science.
[23] Samuel Alizon,et al. The Evolutionary Dynamics of a Rapidly Mutating Virus within and between Hosts: The Case of Hepatitis C Virus , 2009, PLoS Comput. Biol..
[24] B. Walker,et al. Fitness Cost of Escape Mutations in p24 Gag in Association with Control of Human Immunodeficiency Virus Type 1 , 2006, Journal of Virology.
[25] W. Fawzi,et al. Different rates of disease progression of HIV type 1 infection in Tanzania based on infecting subtype. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[26] D. Birx,et al. Defective accessory genes in a human immunodeficiency virus type 1-infected long-term survivor lacking recoverable virus , 1995, Journal of virology.
[27] M. Prins,et al. Differences in CD4 Cell Counts at Seroconversion and Decline Among 5739 HIV-1–Infected Individuals with Well-Estimated Dates of Seroconversion , 2003, Journal of acquired immune deficiency syndromes.
[28] Jeffrey N. Martin,et al. In Vivo Fitness Cost of the M184V Mutation in Multidrug-Resistant Human Immunodeficiency Virus Type 1 in the Absence of Lamivudine , 2008, Journal of Virology.
[29] Jianming Tang,et al. HLA allele sharing and HIV type 1 viremia in seroconverting Zambians with known transmitting partners. , 2004, AIDS research and human retroviruses.
[30] Jacques Fellay,et al. A Whole-Genome Association Study of Major Determinants for Host Control of HIV-1 , 2007, Science.
[31] A. Phillips,et al. Temporal trends in postseroconversion CD4 cell count and HIV load: the Concerted Action on Seroconversion to AIDS and Death in Europe Collaboration, 1985-2002. , 2007, The Journal of infectious diseases.
[32] A S Perelson,et al. Modeling plasma virus concentration during primary HIV infection. , 2000, Journal of theoretical biology.
[33] Alan S. Perelson,et al. High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men , 2010, PLoS pathogens.
[34] Martin A Nowak,et al. Virus evolution within patients increases pathogenicity. , 2005, Journal of theoretical biology.
[35] J. Kostman,et al. Relationship Between HIV Coreceptor Tropism and Disease Progression in Persons With Untreated Chronic HIV Infection , 2009, Journal of acquired immune deficiency syndromes.
[36] Scott Wegner,et al. Is HIV becoming more virulent? Initial CD4 cell counts among HIV seroconverters during the course of the HIV epidemic: 1985-2007. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[37] G. Rutherford,et al. The natural history of transfusion-associated infection with human immunodeficiency virus. Factors influencing the rate of progression to disease. , 1989, The New England journal of medicine.
[38] D. Pillay,et al. The effect of transmitted HIV-1 drug resistance on pre-therapy viral load , 2010, AIDS.
[39] F. Hecht,et al. The Relation Between Symptoms, Viral Load, and Viral Load Set Point in Primary HIV Infection , 2007, Journal of acquired immune deficiency syndromes.
[40] Christl A. Donnelly,et al. HIV-1 Transmitting Couples Have Similar Viral Load Set-Points in Rakai, Uganda , 2010, PLoS pathogens.
[41] K. Crandall,et al. The causes and consequences of HIV evolution , 2004, Nature Reviews Genetics.
[42] Christophe Fraser,et al. Interpretation of correlations in setpoint viral load in transmitting couples. , 2010, AIDS.
[43] A. Telenti,et al. Phylogenetic Approach Reveals That Virus Genotype Largely Determines HIV Set-Point Viral Load , 2010, PLoS pathogens.
[44] T. Déirdre Hollingsworth,et al. Variation in HIV-1 set-point viral load: Epidemiological analysis and an evolutionary hypothesis , 2007, Proceedings of the National Academy of Sciences.
[45] T. Garland,et al. TESTING FOR PHYLOGENETIC SIGNAL IN COMPARATIVE DATA: BEHAVIORAL TRAITS ARE MORE LABILE , 2003, Evolution; international journal of organic evolution.
[46] K. Shianna,et al. Host determinants of HIV-1 control in African Americans. , 2010, The Journal of infectious diseases.
[47] S. Lawn,et al. Contribution of Immune Activation to the Pathogenesis and Transmission of Human Immunodeficiency Virus Type 1 Infection , 2001, Clinical Microbiology Reviews.
[48] C. Petropoulos,et al. Baseline HIV type 1 coreceptor tropism predicts disease progression. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[49] Athanasius F. M. Marée,et al. Small variations in multiple parameters account for wide variations in HIV–1 set–points: a novel modelling approach , 2001, Proceedings of the Royal Society of London. Series B: Biological Sciences.
[50] O. Delaneau,et al. Genomewide Association Study of a Rapid Progression Cohort Identifies New Susceptibility Alleles for Aids (anrs Genomewide Association Study 03) , 2022 .
[51] G. Touloumi. Differences in CD4 cell counts at seroconversion and decline among 5739 HIV-1-infected individuals with well-estimated dates of seroconversion , 2003 .
[52] Carlo Torti,et al. Increasing Clinical Virulence in Two Decades of the Italian HIV Epidemic , 2009, PLoS pathogens.
[53] Sebastian Bonhoeffer,et al. Viral Dynamics and In Vivo Fitness of HIV-1 in the Presence and Absence of Enfuvirtide , 2008, Journal of acquired immune deficiency syndromes.
[54] Winston A Hide,et al. Transmission of HIV-1 CTL Escape Variants Provides HLA-Mismatched Recipients with a Survival Advantage , 2008, PLoS pathogens.
[55] Michael P Busch,et al. Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection , 2003, AIDS.
[56] D. Douek. HIV disease progression: immune activation, microbes, and a leaky gut. , 2007, Topics in HIV medicine : a publication of the International AIDS Society, USA.
[57] Hui Li,et al. Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection , 2008, Proceedings of the National Academy of Sciences.
[58] C. Rouzioux,et al. No evidence of a change in HIV-1 virulence since 1996 in France , 2009, AIDS (London).
[59] J. Kaldor,et al. HIV infection in recipients of blood products from donors with known duration of infection , 1994, The Lancet.
[60] Wendy Hartogensis,et al. HIV RNA level in early infection is predicted by viral load in the transmission source , 2010, AIDS.
[61] David Heckerman,et al. Transmission of HIV-1 Gag immune escape mutations is associated with reduced viral load in linked recipients , 2008, The Journal of experimental medicine.
[62] D Schenzle,et al. A model for AIDS pathogenesis. , 1994, Statistics in medicine.
[63] A. Perelson,et al. Optimizing within-host viral fitness: infected cell lifespan and virion production rate. , 2004, Journal of theoretical biology.
[64] M. Nowak,et al. Specific therapy regimes could lead to long-term immunological control of HIV. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[65] V. Jansen,et al. The dual role of CD4 T helper cells in the infection dynamics of HIV and their importance for vaccination. , 2002, Journal of theoretical biology.
[66] Sebastian Bonhoeffer,et al. Glancing behind virus load variation in HIV-1 infection. , 2003, Trends in microbiology.
[67] Z. Grossman,et al. CD4+ T-cell depletion in HIV infection: Are we closer to understanding the cause? , 2002, Nature Medicine.
[68] Oliver Laeyendecker,et al. Effect of human immunodeficiency virus Type 1 (HIV-1) subtype on disease progression in persons from Rakai, Uganda, with incident HIV-1 infection. , 2008, The Journal of infectious diseases.
[69] Elizabeth T. Cirulli,et al. Common Genetic Variation and the Control of HIV-1 in Humans , 2009, PLoS genetics.
[70] S. Buchbinder,et al. Long‐term HIV‐1 infection without immunologic progression , 1994, AIDS.